FindTrial
Sign In

Exploring the Application Value of Near-Infrared Spectroscopy Technology and Novel Kidney Injury Biomarkers in Predicting Acute Kidney Injury Following Infant Cardiac Surgery

Exploring the Application Value of Near-Infrared Spectroscopy Technology and Novel Kidney Injury Biomarkers in Predicting Acute Kidney Injury Following Infant Cardiac Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098920
Enrollment
Unknown
Registered
2025-03-16
Start date
2025-03-17
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease

Interventions

Observation group:NA

Sponsors

Fuwai Hospital, National Center for Cardiovascular Diseases
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1.Scheduled to undergo elective median sternotomy with cardiopulmonary bypass (CPB) cardiac surgery; 2.Infants (age <= 1 year).

Exclusion criteria

Exclusion criteria: 1. Preoperative renal dysfunction; 2. Renal developmental abnormalities; 3. Local skin damage preventing the monitoring of regional oxygen saturation; 4. Failure to obtain informed consent.

Design outcomes

Primary

MeasureTime frame
Incidence of CSA-AKI;—

Secondary

MeasureTime frame
ICU stay time;Total length of hospital stay;Duration of mechanical ventilation;—

Countries

China

Contacts

Public ContactLiu Jinping

Fuwai Hospital, National Center for Cardiovascular Diseases

liujinping@fuwai.com+86 136 0129 3946

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026